Rocket Lab Q4 Guidance: Sales $270M-$290M vs $265.4M Est
Rocket Lab reported Q3 revenue of $267.83M, beating estimates, but posted a loss of $0.12 per share. The company guided Q4 revenue to $270M-$290M. Shares fell 6.61% in after-hours trading. Rocket Lab's backlog grew to $3.57B, with $1B in new launch contracts. The Neutron rocket's first launch is delayed to 2027. The company plans to acquire Iridium for $8B, with closing expected by mid-2027. Analysts have a Buy rating with an average price target of $103.23.
How this was made
The 30-second read
Why it matters
The earnings miss and guidance shortfall triggered a 6.6% after‑hours decline, highlighting short‑term downside risk.
Market read
The news directly affects RKLB and may influence related aerospace stocks.
What to watch
The Neutron rocket timeline delay and Iridium acquisition financing may create upside if milestones are met.
Background
Rocket Lab reported Q3 results and issued Q4 sales guidance amid a volatile political environment affecting defense spending.
Ticker impact
Q3 revenue beat and Q4 sales guidance of $270M-$290M disclosed, with a loss miss and after‑hours price drop.
likely pressure as the market prices in weaker guidance and the EPS miss
The article provides the first public Q3 results and Q4 guidance, both material for a mid‑cap aerospace firm.
Market effects
Aerospace and defense stocks may face broader weakness due to political uncertainty over defense spending.
U.S. market sentiment could be dampened as the Dow fell over 1,800 points.
Limited to investors tracking space launch providers and defense contractors.
Counterpoint
Despite the miss, the record backlog and cash position could support a longer‑term rebound.
Key entities
- CompanyRocket Lab Corporation
Space launch provider issuing Q3 results and Q4 guidance.
- CompanyIridium
Satellite communications firm being acquired by Rocket Lab.
